Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

bioRxiv logoLink to bioRxiv
[Preprint]. 2026 Sep 22:2026.09.20.753013. [Version 1] doi: 10.64898/2026.09.20.753013

A binuclear copper enzyme platform for enantioconvergent radical (pseudo)halogenation

Xiao-Wang Chen 1, Oluwatosin Maryam Adeyemo 2, Heyu Chen 1, Hongda Chen 1, Ngoc Nguyen 2, Joseph Palazzo 2, Liu-Peng Zhao 1, Ken Lin 1, Binh Khanh Mai 3, Peng Liu 3, Shiliang Tian 2,*, Yang Yang 1,4,5,6,*
PMCID: PMC13622139  PMID: 42818196

Abstract

Despite their intriguing native metalloenzymology, naturally occurring copper enzymes remain largely underexploited for new-to-nature biocatalytic reactions. Herein, we report the systematic investigation and reprogramming of natural copper enzymes to catalyze unnatural free radical (pseudo)halogenation reaction in a highly enantioselective fashion. Evaluating Cu enzymes in the decarboxylative azidation of redox-active esters revealed activity across multiple Cu enzyme families, with type III binuclear Cu enzymes, particularly the Bacillus megaterium tyrosinase (BmTyr), exhibiting superior activity and enantioselectivity across both stabilized and unstabilized alkyl radicals upon further engineering. The strong halide binding affinity of the binuclear Cu system also enabled challenging enantioconvergent bromination, chlorination and isothiocyanation reactions, which remained inaccessible to repurposed nonheme Fe enzymes. Further EPR and UV–visible spectroscopic analyses confirmed the coupled binuclear nature of wild-type and engineered bacterial tyrosinases and provided insights into the origin of their enhanced activity. Collectively, this study establishes binuclear copper enzymes as a powerful platform for new-to-nature stereoselective radical reactions, expanding the scope of metalloenzyme catalysis beyond mononuclear systems.

Introduction

Over the past decade, metalloenzymes have been reprogrammed and evolved into powerful biocatalysts for synthetically valuable stereoselective transformations that operate through mechanisms unknown in nature1–7. In particular, recent work from our laboratory and other researchers has established both heme8–14 and nonheme15–27 Fe enzymes as tunable platforms for a wide range of stereoselective radical transformations, providing a new solution to the longstanding challenge of imposing stereocontrol over free radical intermediates. In contrast to the extensive development of Fe-based systems, naturally occurring metalloenzymes that utilize alternative first-row transition-metal cofactors, particularly copper28, remain largely underexploited for non-native radical biocatalysis7. Although metal substitution in nonheme Fe and Zn enzymes has enabled access to exciting new reactivities29–34, the native coordination environments of these proteins are evolutionarily optimized for Fe or Zn and may not provide an ideal environment for alternative metal ions such as Cu, thereby posing a key limitation of this strategy.

To address these limitations, we set out to systematically evaluate the synthetic potential of natural copper enzymes for enabling new-to-nature radical reactions via a metalloredox mechanism, particularly those that remain challenging to access using reprogrammed Fe enzymes (Fig. 1). In nature, a diverse array of type I, II and III copper enzymes, featuring distinct coordination chemistry (Fig. 1a), have evolved to catalyze various oxidative transformations using O2 or H2O2 as the terminal oxidant28. In contrast to native enzymology, we sought to investigate the potential of Cu enzymes to promote overall redox-neutral transformations under anaerobic conditions via Cu(II)/Cu(I) redox cycling. In particular, we were intrigued by the possibility that copper enzymes could catalyze radical (pseudo)halogenation reactions, including chlorination, bromination, azidation, isothiocyanation and thiocyanation, of non-native substrate classes via a radical rebound mechanism. For several decades, the metallohalogenase literature has been dominated by α-ketoglutarate-dependent nonheme Fe enzymes35,36. In 2025, groundbreaking work by Tang and coworkers reported a rare example of Cu-dependent biosynthetic enzyme capable of catalyzing C–H chlorination of atpenin B (Fig. 1b)37, ushering in a new frontier of metallohalogenase research. From a chemical reactivity perspective, inspired by the enhanced (pseudo)halide binding affinity of Cu(II) centers arising from their softer character relative to Fe(III), we envisioned that copper enzymes could enable a broader range of challenging (pseudo)halogenation reaction.

Fig. 1. Binuclear copper enzymes as a powerful platform for advancing new-to-nature stereoselective radical reactions.

Fig. 1.

a, Coordination chemistry in mono- and binuclear Cu enzymes. b, Natural Cu-dependent halogenase and tyrosinase inhibition by halides. c, New-to-nature biocatalytic enantioconvergent radical (pseudo)halogenation reactions, including azidation, bromination, chlorination and isothiocyanation. d, Proposed mechanism of biocatalytic radical (pseudo)halogenation reactions using binuclear copper enzymes. RL: larger substituent, RS: smaller substituent.

Among natural copper enzymes, we were particularly fascinated by the largely underexplored synthetic potential of binuclear copper enzymes. In native enzymology, bimetallic active sites synergistically harness the redox properties of two proximal metal centers to enable multielectron transformations through mechanisms inaccessible to mononuclear metalloenzymes38. To date, such bimetallic systems, including diiron39 and dicopper enzymes40, have rarely been leveraged for new-to-nature biocatalysis, limiting the exploration of their multimetallic cooperativity for challenging reactivity. In particular, important studies by Solomon41 and Canters42,43 revealed that tyrosinases, members of the type III copper enzyme superfamily, bind (pseudo)halide ions cooperatively to form μ-(pseudo)halide-bridged dicopper intermediates (Cu–X–Cu, X = N3, F, Cl, Br and I) (Fig. 1b). Although (pseudo)halide binding is typically inhibitory to native tyrosinase activity, we envisioned that this strong binding affinity, combined with the unique reactivity of μ-(pseudo)halide-bridged dicopper intermediates, could be harnessed strategically to enable challenging enantioselective radical (pseudo)halogenation chemistry44,45. In particular, by leveraging the exquisite enzymatic stereocontrol over transient free radical intermediates, this dicopper enzyme platform holds the potential to construct minimally differentiated alkyl–alkyl stereocenters, which continue to present substantial synthetic hurdles for state-of-the-art chiral small-molecule copper catalysts46,47.

Our envisioned dual photobiocatalytic cycles for dicopper enzyme-catalyzed radical (pseudo)halogenation are described in Fig. 1d. In the photoredox cycle, the use of an appropriate photosensitizer would generate an alkyl radical intermediate (I) from the corresponding N-hydroxyphthalimide ester substrate 1. Concurrently, in the biocatalytic cycle, the dicopper enzyme (II) binds (pseudo)halide ions, including challenging halides such as bromide and chloride, to form a μ-(pseudo)halide-bridged Cu(II)2 intermediate (III). The photoredox-generated alkyl radical (I) would enter the enzyme active site and react with the copper-bound bridging μ-(pseudo)halide, thereby forming the radical (pseudo)halogenation products (2–5) and generating a mixed-valence Cu(II)/Cu(I) dicopper enzyme state (IV). We hypothesized that electronic coupling between the two proximal Cu(II)/Cu(I) centers would stabilize this mixed-valence intermediate (IV) 28,48,49, thereby facilitating otherwise challenging radical halogenation reactions. Finally, single-electron oxidation of the Cu(II)/Cu(I) state enzyme (IV) by the photoredox catalyst would regenerate the dicopper enzyme (II), thereby completing the catalytic cycle. Herein, we report the successful implementation of this design through the development of dicopper enzyme-catalyzed enantioconvergent (pseudo)halogenation reactions. This platform enables a diverse set of asymmetric radical transformations, including bromination, chlorination and isothiocyanation, which have remained challenging for chiral small-molecule copper catalysts (Fig. 1c). These dicopper enzyme-based transformations expand the chemical landscape of new-to-nature nonheme Fe-based biocatalysis19,20, while providing mechanistic insights into recently discovered copper-dependent biosynthetic halogenation pathways37.

Results and discussion

Evaluation of natural copper enzymes for asymmetric radical azidation and discovery of binuclear Cu tyrosinases as highly effective biocatalysts

To evaluate the potential of naturally occurring Cu-dependent enzymes28 in promoting unnatural radical (pseudo)halogenation reactions, we built an in-house collection of various type I, II and III copper proteins and multinuclear copper oxidases (MCOs)28 that could be conveniently expressed in Escherichia coli at high expression levels (Fig. 2). This Cu enzyme library encompassed type I blue copper proteins including azurin, amicyanin and their mutants; type II copper enzymes including galactose oxidases (GOases) and copper amine oxidases (CAOs); type III copper enzymes including various tyrosinases; as well as MCOs, including laccases. Collectively, our in-house Cu-dependent protein library includes mononuclear, binuclear and multinuclear Cu enzymes with diverse Cu coordination chemistry, thereby setting the stage for the discovery of new-to-nature Cu enzyme-catalyzed reactivity.

Fig. 2. Discovery and optimization of copper-dependent enzyme-catalyzed enantioselective photometallobiocatalytic decarboxylative azidation.

Fig. 2.

a, Evaluation of natural Cu enzymes for photometallobiocatalytic azidation. b, Optimization of photocatalysts and control experiments. Reaction conditions: 1a (1.0 equiv, 4.0 mM), NaN3 (2.0–5.0 equiv, 4.0–20.0 mM), 0.5–1 mol% Cu-dependent enzyme (20–40 μM), 1 mol% CuSO4 (40 μM), 1–5 mol% photocatalyst (40 μM–200 μM), hυ (440 or 520 nm), KPi buffer (200 mM, pH 7.4), 20 °C, 12 h.

To investigate whether naturally occurring Cu enzymes could facilitate radical-mediated (pseudo)halogenation reactions, we first evaluated their catalytic activity in photobiocatalytic azidation using racemic N-hydroxyphthalimide ester (rac)-1a as the radical precursor. Under visible light irradiation (440 nm), in the presence of 5 mol% fluorescein as the photosensitizer, the use of type I blue copper proteins, including azurin50 from Pseudomonas aeruginosa and amicyanin51 from Paracoccus denitrificans as well as their single mutant azurin M121G52 possessing an open coordination site, provided <1% yield of 2a with no enantioselectivity. The type II copper enzyme Escherichia coli copper amine oxidase (EcCAO)53 also showed minimal azidation activity. Interestingly, other type II copper enzymes exhibited low levels of activity and measurable enantioselectivity. The use of a thermophilic lytic polysaccharide monooxygenase from Thermobifida fusca (TfAA10A)54 afforded 2a in 4% yield and 52:48 e.r., while the employment of an engineered variant of galactose oxidase from Fusarium graminearum (FgGOase)55 gave rise to 2a in 3% yield and 55:45 e.r.. Collectively, these results indicated the potential of these type II mononuclear Cu enzymes in promoting asymmetric radical azidation.

Among all the natural Cu enzymes we evaluated, bacterial tyrosinases, a class of type III binuclear Cu enzymes featuring a coupled binuclear Cu center, displayed the highest initial activity and enantioselectivity. In particular, tyrosinase from Bacillus megaterium (BmTyr)56 furnished azidation product 2a in 15% yield and excellent enantioselectivity (97:3 e.r.), clearly demonstrating enzymatic conversion of (rac)-1a. The archaeal tyrosinase from Candidatus Nitrosopumilus koreensis (CNkTyr)57 possessing a more solvent exposed active site exhibited enhanced activity, providing 2a in 20% yield albeit with a slightly reduced enantioselectivity (65:35 e.r.). Other tyrosinases, including the Burkholderia thailandensis tyrosinase (BtTyr)58 and Hahella sp. CCB MM4 tyrosinase (HcTyr)59 afforded 2a in 0% yield and 4% yield (55:45 e.r.), respectively. Given the excellent stereocontrol and initial activity of BmTyr, this type III binuclear Cu enzyme was selected for further optimization and protein engineering.

Using 0.5 mol% BmTyr as the biocatalyst, we next evaluated a range of photocatalysts in the current photobiocatalytic asymmetric azidation. Transition metal-based photocatalysts, showed low levels of activity and reduced enantioselectivity (Fig. 2b, entries 1 and 2). Although the use of an acridinium salt also afforded low yields, excellent enantioselectivity of 2a was observed (93:7 e.r., entry 3). Organic photocatalysts from the rhodamine family such as rhodamine B delivered 2a in 11% yield and 97:3 e.r. (entry 4). Other organic dyes from the fluorescein family, such as eosin Y, a tetrabrominated fluorescein, provided similar results as the parent compound fluorescein (14% yield, 97:3 e.r., entry 5). Interestingly, a dibrominated analog of fluorescein, dibromofluorescein, demonstrated superior activity compared to both fluorescein and eosin Y, providing azidation product 2a in 23% yield while maintaining excellent enantioselectivity (98:2 e.r., entry 6). Reducing the loading of dibromofluorescein to 1 mol% slowed down photoinduced free radical generation and resulted in a further improved yield of 36% (entry 7). It was found that only 1 to 2 equiv of NaN3 was required for this tyrosinase-catalyzed asymmetric radical azidation (Supplementary Table 6), indicating enhanced azide binding affinity of binuclear copper tyrosinases relative to nonheme Fe enzymes19,20. Importantly, lowering the NaN3 increased the yield of 2a to 40% by suppressing the non-enzymatic formation of acylazide side products derived from 1a (entry 8). Irradiation at 520 nm further improved the yield of 2a, due to the stronger absorption of dibromofluorescein at this wavelength (entries 9 and 10). Carrying out this tyrosinase-catalyzed azidation in the presence of added transition-metal ions including Mn2+, Fe2+, Co2+ and Ni2+ spanning a wide range of concentrations of did not lead to azidation product formation (entry 13), confirming the critical role of copper in this unnatural radical transformation.

Protein engineering and substrate scope of binuclear Cu tyrosinase-catalyzed enantioselective radical azidation

With the optimized conditions established for wild-type BmTyr, we next performed semi-rational protein engineering by targeting active-site and substrate entrance tunnel hydrophobic residues, with the aim to modify the active site to better accommodate the hydrophobic alkyl radical intermediates in the new-to-nature chemistry. Guided by the crystal structure of BmTyr (PDB ID: 6EI4)56, residues proximal to the binuclear Cu centers supported by six histidine residues (H42, H60 and H69 for Cu1; H204, H208 and H231 for Cu2) were targeted to construct a mutant library to investigate the effects of active-site residues on non-native azidation. It was found that the inclusion of a valine to alanine mutation at residue 218, residing in a flexible loop flanking the binuclear Cu centers (V218A), was beneficial, leading to an improved azidation yield of 56% (entry 2). By reducing the size of the amino acid residue 218 close to the Cu centers, V218A better accommodated organic substrates to approach the reactive Cu centers. Using BmTyr V218A as the parent, another beneficial mutation N205M adjacent to the Cu-binding residue H204 was discovered, further enhancing the yield of 2a to 70% (entry 3). Collectively, the engineered tyrosinase double mutant BmTyr V218A N205M allowed this non-native photometallobiocatalytic radical azidation to occur with improved efficiency in an enantioselective fashion. Importantly, ablating either Cu center from the binuclear Cu enzyme by mutating all three Cu-binding histidine residues to alanine (BmTyr V218A N205M H42A H60A H69A, entry 4; BmTyr V218A N205M H204A H208A H231A, entry 5) led to drastically diminished activity and enantioselectivity, highlighting the essential role of the binuclear Cu center in facilitating this asymmetric radical azidation.

With this engineered BmTyr V218A N205M double mutant in hand, we next examined the substrate scope of radical decarboxylative azidation (Fig. 3b). It was found that redox-active esters bearing a para- (2b), a meta- (2c) and an ortho- (2d) substituent on the aromatic ring were compatible with the engineered binuclear Cu biocatalyst. Halogen substituents including a fluoro (2e), a chloro (2f), and a bromo (2g) were readily accommodated under these photobiocatalytic conditions. Electron-donating groups such as a methoxy (2h) and electron-withdrawing groups such as a trifluoromethyl (2i) at the para-position of the aromatic ring were also compatible, although reduced enantioselectivity was observed for the para-methoxy substrate. Additionally, our engineered BmTyr V218A N205M variant could also readily transform an extended α-ethyl substrate (2j), indicating the potential of this binuclear Cu enzyme to accommodate larger substrates.

Fig. 3. Engineering of the binuclear Cu tyrosinase from Bacillus megaterium for enantioselective photometallobiocatalytic radical azidation.

Fig. 3.

a, Protein engineering of BmTyr for the enantioselective decarboxylative azidation. The active-site illustration of BmTyr was generated from 6EI4 (PDB ID) using PyMOL. Mutated residues are highlighted in marine. b, Substrate scope of enantioselective photometallobiocatalytic decarboxylative azidation. Reaction conditions: N-hydroxyphthalimide ester 1 (1.0 equiv, 4.0 mM), NaN3 (2 equiv, 8.0 mM), 1 mol% BmTyr V218A N205M (40 μM), 2 mol% CuSO4 (80 μM), 1 mol% dibromofluorescein (40 μM), hυ (520 nm), KPi buffer (200 mM, pH 7.4), 20 °C, 12 h. Biocatalytic reactions were carried out in triplicate and average yields and standard deviations were reported. See the Supplementary Information for details. a1 mol% wt BmTyr was used. b1 mol% BmTyr R209M was used. c440 nm in lieu of 520 nm.

In cooperative photobiocatalysis, the efficient and enantioselective conversion of unstabilized alkyl radicals, namely radicals lacking a neighboring stabilizing group such as an aryl and an α-carbonyl substituent, continues to present a significant challenge due to their short lifetimes. In particular, with previously developed nonheme Fe biocatalyst systems, transformations involving these unstabilized aliphatic radicals did not provide synthetically useful yields or good stereocontrol19. We therefore investigated whether binuclear copper enzymes could enable the conversion of these reactive radical intermediates in a productive manner. It was found that wildtype BmTyr allowed the transformation of homobenzylic substrates to the corresponding azidation products (2k–2m) in good yields and enantioselectivities. Heterocycles, including a thiophene (2l) and a furan (2m), were compatible under these reaction conditions. Furthermore, fully aliphatic substrates lacking an adjacent stabilizing aromatic substituent, such as aliphatic substrates bearing a tetrahydropyran (2n), a piperidine (2o) and a gem-difluorinated cyclohexyl (2p) moiety, could also be effectively transformed by BmTyr R209M or BmTyr V218A N205M with excellent enantioselectivity. Additional secondary alkyl substrates bearing a phenylethyl (2q), and an isopentenyl (2r) group at the α carbon, could also be transformed in an enantioselective fashion. Importantly, the ability to effectively distinguish between two similar alkyl substituents represented an ongoing challenge in asymmetric alkyl cross-coupling reactions46,47, and our results highlighted the excellent potential of binuclear copper enzymes to solve difficult problems in asymmetric catalysis. Furthermore, the efficient and enantioselective conversion of unstabilized alkyl radicals with binuclear copper enzymes is highly complementary to nonheme Fe-based enzymatic systems.

Tyrosinase-catalyzed enantioselective radical bromination

Compared to azidation, biocatalytic radical bromination via an unnatural mechanism remains challenging, in part due to the substantially lower binding affinity of the bromide ion for metallocofactors in aqueous solution. Furthermore, catalytic asymmetric radical bromination with small-molecule transition-metal catalysts applicable to a broad range of organic substrates has remained a difficult task in enantioselective catalysis. After establishing the tyrosinase-catalyzed enantioselective azidation, we next questioned whether this radical rebound reactivity could be expanded to bromides, giving rise to unnatural copper-dependent halogenases, an activity which is exceedingly rare among natural copper enzymes. Previous studies showed that halide ions are potent inhibitors for tyrosinases in their native activity due to the bridging μ2-binding mode of the halide anion with both copper centers42,43. Although this strong binding is deleterious to the native tyrosinase activity, we posited that such enhanced bromide binding with a binuclear Cu–Br–Cu intermediate might enable otherwise highly challenging radical bromination reactions. Indeed, using (rac)-1n as the model substrate, in the presence of 40 equiv bromide ion, the use of 1 mol% dibromofluorescein and 1 mol% wt Bacillus megaterium tyrosinase provided the desired alkyl bromide product 3a in 47% yield and 88:12 e.r. (Fig. 4a, entry 1). Re-evaluation of a wider range of photosensitizers revealed that the parent unsubstituted fluorescein provided improved yield and enantioselectivity (64% yield and 90:10 e.r., entry 2). To further enhance the activity of this dicopper brominase, we evaluated a focused collection of BmTyr variants. It was found that the R209M mutant of BmTyr furnished further improved activity, giving rise to 3a in 80% yield and 90:10 e.r. (entry 3). Active-site residue 209 lies close to the copper-binding H208, and the inclusion of R209M may facilitate copper recruitment and binding in the dicopper binding site60. Similar to our observation for biocatalytic radical azidation, eliminating either Cu center from the binuclear Cu system (BmTyr R209M H42A H60A H69A, entry 4; BmTyr R209M H204A H208A H231A, entry 5) drastically reduced the activity and enantioselectivity of the present Cu-dependent biocatalyst.

Fig. 4. Binuclear copper enzyme-catalyzed enantioselective decarboxylative bromination of redox-active esters.

Fig. 4.

a, Optimization of photobiocatalytic asymmetric decarboxylative bromination of redox-active esters. The active-site illustration of BmTyr was generated from 6EI4 (PDB ID) using PyMOL. Mutated residues were highlighted in marine. b, Substrate scope of photobiocatalytic asymmetric decarboxylative bromination of redox-active esters. Reaction conditions: redox-active ester 1 (1.0 equiv, 4.0 mM), NaBr (40 equiv, 160 mM), 1 mol% BmTyr variant (40 μM), 2 mol% CuSO4 (80 μM), 1 mol% fluorescein (40 μM), hυ (440 or 520 nm), 200 mM KPi buffer (pH 7.4), 20 °C, 12 h. Biocatalytic reactions were carried out in triplicate and average yields and standard deviations were reported. See the Supplementary Information for details. a520 nm in lieu of 440 nm.

With these optimized reaction conditions in hand, we surveyed the substrate scope of this enantioselective photobiocatalytic decarboxylative bromination. It was found that functionalized cyclic alkyl substituents were compatible with this transformation. For example, a substrate bearing a 4,4-gem-difluorocyclohexyl group (3b) could be transformed in excellent enantioselectivity (92:8 e.r.). N-Boc-piperidine (3c) and tetrahydropyran (3d) substituents were also readily accommodated. Using BmTyr V218A N205M possessing a further expanded active-site, the more challenging enantiodifferentiation between a tetrahydropyran group and an ethyl group (3d) could also be realized with good levels of enantiocontrol (90:10 e.r.). Furthermore, without additional protein engineering, homobenzylic (3e) and 2-(4-phenylbutyl) (3f) substrates also underwent this photobiocatalytic transformation with promising levels of enantioselectivity. Given the high similarity between the methyl and the primary alkyl substituent flanking the radical center, these results further underscored the excellent potential of binuclear copper enzymes in tackling challenging enantioinduction problems. Further enzyme engineering to improve enantioselectivity through high-throughput experimentation is currently underway in our laboratory.

Tyrosinase-catalyzed enantioselective radical chlorination and isothiocyanation

Furthermore, we found that binuclear copper enzymes could also facilitate other types of radical halogenation reactions, including chlorination and isothiocyanation (Fig. 5). Using racemic redox-active ester (rac)-1n as the substrate, in the presence of 40 equiv chloride ion, wt BmTyr catalyzed enantioselective radical chlorination to afford the corresponding alkyl chloride in 53% yield and 85:15 e.r. (Fig. 5a). When sodium thiocyanate was used, the binuclear copper enzyme BmTyr transformed (rac)-1n into the isothiocyanated product (5, 37% yield, 94:6 e.r.) as the major product, with an isothiocyanation : thiocyanation ratio of 83:17 (Fig. 5b). SCN− is an ambident anion, and literature studies are consistent with nitrogen binding to copper in small-molecule systems61. Importantly, this binuclear Cu enzyme furnished an ambident selectivity complementary to nonheme Fe enzyme–catalyzed radical transformations using thiocyanate anion, where our engineered Pseudomonas putida metapyrocatechase (PpMPC) variant PpMPC I291L L155F I204L afforded the alkyl thiocyanate product exclusively in 54% yield and 95:5 e.r.20. Collectively, these results revealed the distinct reactivity of copper enzymes in radical functionalization reactions, highlighting the complementary activity profiles of Cu and Fe-based nonheme enzyme systems.

Fig. 5. Binuclear copper enzyme-catalyzed enantioselective decarboxylative chlorination and isothiocyanation.

Fig. 5.

Chlorination conditions: redox-active ester 1n (1.0 equiv, 4.0 mM), NaCl (40.0 equiv, 160 mM), 2.5 mol% wt BmTyr (100 μM), 5 mol% CuSO4 (200 μM), 1 mol% fluorescein (40 μM), hυ (440 nm), 200 mM KPi buffer (pH 7.4), 20 °C, 12 h. Isothiocyanation conditions: redox-active ester 1a (1.0 equiv, 4.0 mM), NaSCN (5.0 equiv, 20 mM), 2.5 mol% wt BmTyr (100 μM), 5 mol% CuSO4 (200 μM), 1 mol% fluorescein (40 μM), hυ (520 nm), 200 mM KPi buffer (pH 7.4), 20 °C, 12 h.

EPR and UV–visible spectroscopic characterization of dinuclear Cu enzymes

Tyrosinases typically feature a coupled binuclear dicopper active site, in which each copper ion is coordinated by three conserved histidine residues28,62. However, BmTyr displays distinct copper-binding behavior. Its crystal structure reveals the presence of both dicopper and monocopper active sites63. Consistent with this observation, titration of two equivalents of CuSO4 followed by removal of unbound copper using a desalting column resulted in clear mononuclear copper EPR signals in both wild-type and mutant BmTyr (Figs. 6a and 6b). EPR spectral simulations indicate that both variants share a similar mononuclear copper site, characterized by g values of (2.24, 2.07, 2.05) and a copper hyperfine coupling of 190 × 10−4 cm−1 (Figs. 6a and 6b), consistent with a type 2 copper center with dx2-y2 ground state28.

Figure 6. Spectroscopic characterization of copper speciation and (pseudo)halide binding in wild-type and mutant Bm tyrosinase.

Figure 6.

a, Experimental (red) and simulated (blue) X-band EPR spectra of wt BmTyr in the absence and presence of ligands (N3− and SCN−). b, Experimental (red) and simulated (blue) X-band EPR spectra of BmTyr V218A N205M in the absence and presence of ligands (N3− and SCN−). c, Distribution of copper species in wt BmTyr and BmTyr V218A N205M determined by spin-counting EPR and biquinoline assay, showing the average percentages of mononuclear and binuclear copper species from triplicate measurements. Error bars represent standard deviations (wt BmTyr: ±5.2% mononuclear, ±0.6% binuclear; BmTyr V218A N205M: ±8.3% mononuclear, ±4.6% binuclear). d, UV–visible difference spectra (ΔA) from azide titration of BmTyr V218A N205M in 50 mM Tris buffer, referenced to the 0 mM azide spectrum. e, UV–visible difference spectra (ΔA) from thiocyanate titration of BmTyr V218A N205M in 50 mM Tris buffer, referenced to the 0 mM thiocyanate spectrum. f, UV–visible difference spectra (ΔA) from bromide titration of BmTyr V218A N205M in 50 mM Tris buffer, referenced to the 0 mM bromide spectrum. g, Azide binding isotherm for wt BmTyr derived from absorbance changes at 350 nm. h, Azide binding isotherm for BmTyr V218A N205M derived from absorbance changes at 360 nm. i, In situ UV–visible spectroscopy of photobiocatalytic decarboxylative azidation with BmTyr V218A N205M.

To quantify the distribution between mono- and dicopper species under catalytic conditions, we combined spin-counting EPR with a colorimetric biquinoline assay. The coupled binuclear type III copper site is EPR-silent in its Cu(II)2 state due to strong antiferromagnetic coupling gives an overall S = 0 ground state, whereas mononuclear copper remains EPR-active in its Cu(II) form. Thus, spin-counting EPR was used to determine the concentration of mononuclear copper, while the biquinoline assay provided the total copper concentration. The amount of coupled binuclear copper was then calculated as the difference between total and mononuclear copper. As shown in Fig. 6c, the total copper concentration in the BmTyr V218A N205M is 291 μM, of which 42 μM corresponds to mononuclear copper. This yields a coupled binuclear copper concentration of 124 μM (two Cu per site). These results indicate that, under catalytic conditions, 65% of BmTyr V218A N205M is populated by dicopper sites, whereas 28% contains a single copper ion. A similar distribution is observed in the wild-type BmTyr, with 63% and 26% of the enzyme populated by di- and mononuclear copper sites, respectively (Fig. 6c). Additionally, it was found that holo enzyme reconstitution with Cu(MeCN)4BF4 under anaerobic conditions led to nearly quantitative formation of binuclear Cu(I) species, as determined by biquinoline assays. The reconstituted, and air-treated BmTyr enzyme sample displayed similar catalytic activity and enantioselectivity in photobiocatalytic azidation and bromination (see Supplementary Figs. 15 and 16 for details).

Although the coupled binuclear copper site is the predominant form of mutant BmTyr under catalytic conditions, we next sought to determine which copper species—binuclear or mononuclear—is catalytically relevant. Because the mononuclear copper site is EPR-active, we first examined (pseudo)halide binding to both mutant and wild-type enzymes using EPR spectroscopy. As shown in Fig. 6a, addition of a 20-fold excess of azide or thiocyanate resulted in no detectable perturbation in the EPR spectra, suggesting that the mononuclear copper site either does not bind (pseudo)halides or binds them only very weakly. Thus, the mononuclear copper species is likely not involved in catalysis under our photobiocatalytic conditions. We then probed (pseudo)halide binding to the coupled binuclear copper site using UV–visible absorption spectroscopy. Upon addition of azide to the mutant enzyme, a new ligand-to-metal charge-transfer (LMCT) band at 360 nm was observed (Fig. 6d, see Supplementary Figs. 8 and 10 for details). Similar LMCT features were reported for azide binding in both tyrosinases and synthetic dicopper complexes41,64–66. Fitting of the titration data provided a dissociation constant (Kd) of (4.6 ± 0.9) mM for wt BmTyr and (1.1 ± 0.2) mM for BmTyr V218A N205M respectively (Figs. 6g and 6h). This value is consistent with reported affinities for azide binding to binuclear copper sites in tyrosinases (typically 1–2 mM)67. In contrast, azide binding to mononuclear copper centers is significantly weaker; for example, reported Kd values are 11 mM for Cu/Zn superoxide dismutase68 and 18 mM for the E2 domain of the amyloid precursor protein69. Consistent with this assignment, titration with SCN− and Br− also induced perturbations in the LMCT at 330 nm characteristic of the type-3 copper site in the mutant enzyme (Figs. 6e and 6f, see Supplementary Figs. 12 and 14 for details). Although the lower levels of binding affinities for these ligands preclude the determination of dissociation constants under our conditions, their spectral effects support analogous interaction with the binuclear copper center. This behavior is also consistent with previous studies showing that halide ions inhibit tyrosinase activity through binding at the dicopper active site42. Furthermore, in situ UV–visible spectroscopy was used to probe the formation of binuclear Cu azide intermediates under catalytically relevant conditions in the presence of the redox-active ester substrate, dibromofluorescein and NaN3. During the product-forming, catalytic turnover conditions, an absorption at 360 nm corresponding to the binuclear Cu azide charge transfer band was observed. This feature was not present before the addition of NaN3 (Fig. 6i, see Supplementary Figs. 19 and 20 for details). These results further confirmed the formation of the binuclear Cu azide intermediate under photobiocatalytic conditions, further supporting its involvement in catalysis. Taken together, these results establish that the coupled binuclear copper site is both the dominant species under catalytic conditions and the catalytically relevant center for the new-to-nature (pseudo)halogenation chemistry, enabling (pseudo)halide binding and transfer to the photoredox-generated radical intermediate.

Additionally, to probe the origin of activity difference between structurally related photosensitizers fluorescein, dibromofluorescein and Eosin Y. We performed fluorescence anisotropy titration to determine the binding affinity between the photocatalysts and BmTyr V218A N205M used in our study (Extended Data Fig. 1). Fluorescence anisotropy titration with fluorescein showed no saturation within the investigated concentration regime, indicating an estimated Kd of (850 ± 50) μM. In contrast, the Kd value of dibromofluorescein with BmTyr V218A N205M was determined to be (14.0 ± 1.0) μM. Furthermore, Eosin Y, a tetrabrominated fluorescein derivative, exhibited a further enhanced binding affinity, with a Kd of (5.1 ± 0.2) μM. These results indicated a substantially stronger binding of halogenated fluorescein congeners, including dibromofluorescein and Eosin Y, relative to that of fluorescein. Thus, we ascribe the contrasting activity of these structurally related dyes in part to their differential binding affinities toward the metalloenzyme catalyst.

Conclusion

In summary, we established binuclear copper enzymes as a powerful platform for enabling new-to-nature stereoselective radical transformations. Through the investigation of diverse natural copper enzymes, we demonstrated that type III dicopper tyrosinases could be repurposed to catalyze enantioselective radical (pseudo)halogenation reactions, including bromination, chlorination, azidation and isothiocyanation. Mechanistic and spectroscopic studies revealed that the binuclear copper center plays a central role in facilitating these transformations, providing both efficient (pseudo)halide binding and a favorable environment for radical coupling. These findings highlight the unique reactivity of bimetallic enzymes enabled by multimetallic cooperativity in the context of new-to-nature enzymology, opening up new avenues for advancing asymmetric radical transformations that remain challenging for small-molecule catalysts and mononuclear metalloenzymes. In particular, the ability of dicopper enzymes to engage and transform highly reactive, unstabilized alkyl radicals into products bearing a minimally differentiated alkyl-alkyl stereocenter addresses a longstanding challenge in asymmetric catalysis. We anticipate that the integration of multimetallic enzyme scaffolds with non-native reaction design will unlock previously inaccessible transformations at the interface of biocatalysis and synthetic chemistry.

Methods

Expression of BmTyr variants.

E. coli BL21(DE3) cells harboring recombinant plasmid encoding the appropriate BmTyr variant were grown in LBamp media (50 mL, with 0.10 mg/mL ampicillin) at 37 °C and 250 rpm for ca. 6 h, until OD600 reached 0.6–0.8 (mid to late log phase). Preculture (50.0 mL, 5% v/v) was used to inoculate 1 L TB media supplemented with 0.10 mg/mL ampicillin (TBamp) in a 2 L Erlenmeyer flask. The culture was incubated at 37 °C and 230 rpm for 3 h to reach an OD600 of ca. 1.5. The culture was then cooled on ice for 20 min and induced with 0.5 mM isopropyl β-D-1-thiogalactopyranoside (IPTG, final concentrations). Protein expression was performed at 30 ℃ and 200 rpm for 16 h. The cells were then transferred to a conical tube (50 mL) and harvested by centrifugation (3,434 g, 4 min, 4 °C) using an Eppendorf 5910R tabletop centrifuge.

General Procedure for enantioselective photobiocatalytic azidation.

Purified BmTyr variant (ca. 29 mg/mL, 0.8 mM, 50 μL) was allowed to thaw and kept on ice. In a Coy anaerobic chamber, the following stock solutions were prepared: redox-active ester 1 (200 mM in degassed DMSO), dibromofluorescein (2.0 mM in degassed DMSO), NaN3 (400 mM in degassed dd H2O), CuSO4 (4.0 mM in degassed dd H2O). To a one-dram vial containing a stir bar were added 890 μL degassed KPi buffer (200 mM, pH 7.4), ca. 50 μL BmTyr variant (the volume of the BmTyr stock solution was adjusted according to the concentration of the enzyme sample) and 20 μL CuSO4 stock solution, which was allowed to incubate for 1 min on a microplate shaker at 600 rpm. Followed by the addition of 20 μL redox-active ester 1 stock solution, 20 μL NaN3 stock solution and 20 μL dibromofluorescein stock solution. The final reaction volume was 1000 μL; the final concentrations of each reaction component were as follows: 4.0 mM of redox-active ester 1, 8.0 mM NaN3, 80 μM CuSO4, 40 μM BmTyr variant and 40 μM dibromofluorescein. The vials were sealed, removed from the Coy anaerobic chamber and placed in a Shanghai 3S photoreactor (300 rpm, 20 °C) and illuminated at the indicated wavelength (440 nm or 520 nm). After 12 h, 1000 μL of a mesitylene solution (0.50 mM in EtOAc, used for chiral GC analysis) or (0.50 mM in i-Pr2O, used for chiral HPLC analysis) was added to the mixture. The vial was sealed with a screw cap and vortexed. The resulting mixture was transferred to a 2 mL microcentrifuge tube and centrifuged (15,000 rpm, 10 min) using an Eppendorf 5424R centrifuge to separate the organic and aqueous layers. The organic layer (600 μL) was transferred to a 2 mL GC vial and analyzed by chiral GC or HPLC.

General Procedure for enantioselective photobiocatalytic bromination.

Purified enzyme (ca. 29 mg/mL, 0.8 mM, 50 μL) was allowed to thaw and kept on ice. In a Coy anaerobic chamber, the following stock solutions were prepared: redox-active ester 1 (200 mM in degassed DMSO), fluorescein (2.0 mM in degassed DMSO), NaBr (178 mM in 200 mM KPi buffer, pH 7.4), CuSO4 (4.0 mM in degassed dd H2O). To a one-dram vial containing a stir bar were added 900 μL NaBr stock solution, ca. 50 μL BmTyr variant (the volume of the BmTyr stock solution was adjusted according to the concentration of the enzyme sample) and 20 μL CuSO4 stock solution, which was allowed to incubate for 1 min on a microplate shaker at 600 rpm. Followed by the addition of 20 μL redox-active ester 1 stock solution and 20 μL fluorescein stock solution. The final reaction volume was 1000 μL; the final concentrations of each reaction component were as follows: 4.0 mM redox-active ester 1, 160 mM NaBr, 80 μM CuSO4, 40 μM BmTyr variant and 40 μM fluorescein. The vials were sealed, removed from the Coy anaerobic chamber and placed in a Shanghai 3S photoreactor (300 rpm, 20 °C) and illuminated with indicated wavelength (440 nm or 520 nm). After 12 h, 1000 μL of a mesitylene solution (0.50 mM in EtOAc, used for chiral GC analysis) or (0.50 mM in i-Pr2O, used for chiral HPLC analysis) was added to the mixture. The vial was sealed with a screw cap and vortexed. The resulting mixture was transferred to a 2 mL microcentrifuge tube and centrifuged (15,000 rpm, 10 min) using an Eppendorf 5424R centrifuge to separate the organic and aqueous layers. The organic layer (600 μL) was transferred to a 2 mL GC vial and analyzed by chiral GC or HPLC.

Extended Data

Extended Data Fig. 1. Fluorescence anisotropy titration measurements with BmTyr V218A N205M.

Extended Data Fig. 1

a, Determination of Kd for fluorescein binding to BmTyr V218A N205M. b, Determination of Kd for dibromofluorescein binding to BmTyr V218A N205M. c, Determination of Kd for Eosin Y binding to BmTyr V218A N205M.

Acknowledgements

We are grateful to the National Institutes of Health (R35GM147387 to Y.Y. and R35GM155016 to S.T.) for supporting the experimental work and the National Science Foundation (CHE-2400087 to P.L.) for supporting the computational work. Y.Y. is an Alfred P. Sloan Research Fellow (FG-2024-22244), a Camille Dreyfus Teacher-Scholar Awardee (TC-25-084), a David & Lucile Packard Fellow (2023-76169) and a Howard Hughes Medical Institute Freeman Hrabowski Scholar. Computations were carried out at the University of Pittsburgh Center for Research Computing and Data and the Advanced Cyberinfrastructure Coordination Eco-system: Services & Support (ACCESS) Program, supported by NSF awards OAC-2117681, OAC-1928147, OAC-1928224 and CHE-260005.

Footnotes

Competing interests

Y.Y. and X.-W.C. are inventors on a patent application submitted by the University of California Santa Barbara that covers compositions, systems, and methods for biocatalytic (pseudo)halogenation with Cu enzymes. The remaining authors declare no competing interests.

Data availability

All data are available in the main text and the Supplementary Information. Plasmids encoding engineered tyrosinase variants reported in this study are available for research purposes from Y.Y. under a material transfer agreement with the University of California Santa Barbara.

References

  • 1.Renata H., Wang Z. J. & Arnold F. H. Expanding the Enzyme Universe: Accessing Non-Natural Reactions by Mechanism-Guided Directed Evolution. Angew. Chem. Int. Ed. 54, 3351–3367 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Brandenberg O. F., Fasan R. & Arnold F. H. Exploiting and engineering hemoproteins for abiological carbene and nitrene transfer reactions. Curr. Opin. Biotech. 47, 102–111 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Chen K. & Arnold F. H. Engineering new catalytic activities in enzymes. Nat. Catal. 3, 203–213 (2020). [Google Scholar]
  • 4.Yang Y. & Arnold F. H. Navigating the Unnatural Reaction Space: Directed Evolution of Heme Proteins for Selective Carbene and Nitrene Transfer. Acc. Chem. Res. 54, 1209–1225 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Klaus C. & Hammer S. C. New catalytic reactions by enzyme engineering. Trends Chem. 4, 363–366 (2022). [Google Scholar]
  • 6.Buller R. et al. From nature to industry: Harnessing enzymes for biocatalysis. Science 382, eadh8615 (2023). [DOI] [PubMed] [Google Scholar]
  • 7.Fu W., Zhao L.-P. & Yang Y. Metalloenzyme-Catalyzed Radical Reactions Unknown or Uncommon in Native Enzymology. Chem. Rev. 126, 4135–4188 (2026). [DOI] [PubMed] [Google Scholar]
  • 8.Zhou Q., Chin M., Fu Y., Liu P. & Yang Y. Stereodivergent atom-transfer radical cyclization by engineered cytochromes P450. Science 374, 1612–1616 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fu W. et al. Enzyme-controlled stereoselective radical cyclization to arenes enabled by metalloredox biocatalysis. Nat. Catal. 6, 628–636 (2023). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Fu W. et al. A metalloenzyme platform for catalytic asymmetric radical dearomatization. Nat. Chem. 16, 1999–2008 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Fu W. et al. Catalytic Enantioselective Smiles Rearrangement Enabled by the Directed Evolution of P450 Radical Aryl Migratases. J. Am. Chem. Soc. 147, 12197–12205 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Zhang X., Chen D., Álvarez M. & Ward T. R. Repurposing haemoproteins for asymmetric metal-catalysed H atom transfer. Nature 644, 381–390 (2025). [DOI] [PubMed] [Google Scholar]
  • 13.Vallapurackal J. et al. Biocatalytic, asymmetric radical hydrogenation of unactivated alkenes. Science 390, 1050–1056 (2025). [DOI] [PubMed] [Google Scholar]
  • 14.Wang H. et al. Stereoselective photometallobiocatalytic cross-coupling of organoboron reagents and diazo compounds via an outer-sphere mechanism. Nat. Catal. 9, 530–541 (2026). [Google Scholar]
  • 15.Rui J. et al. Directed evolution of nonheme iron enzymes to access abiological radical-relay C(sp3)–H azidation. Science 376, 869–874 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Zhao L.-P. et al. Biocatalytic enantioselective C(sp3)–H fluorination enabled by directed evolution of non-haem iron enzymes. Nat. Synth. 3, 967–975 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Zhao Q. et al. Engineering non-haem iron enzymes for enantioselective C(sp3)–F bond formation via radical fluorine transfer. Nat. Synth. 3, 958–966 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Zhang J. G., Huls A. J., Palacios P. M., Guo Y. & Huang X. Biocatalytic Generation of Trifluoromethyl Radicals by Nonheme Iron Enzymes for Enantioselective Alkene Difunctionalization. J. Am. Chem. Soc. 146, 34878–34886 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Rui J. et al. Merging photoredox with metalloenzymatic catalysis for enantioselective decarboxylative C(sp3)‒N3 and C(sp3)‒SCN bond formation. Nat. Catal. 7, 1394–1403 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhao L.-P. et al. Cooperative Photometallobiocatalysis: Nonheme Fe Enzyme-Catalyzed Enantioconvergent Radical Decarboxylative Azidation, Thiocyanation, and Isocyanation of Redox-Active Esters. Angew. Chem. Int. Ed. 64, e202506361 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Huls A. J. et al. Biocatalytic Olefin Difunctionalization for Synthesis of Chiral 2-Azidoamines Using Nonheme Iron Enzymes. Angew. Chem. Int. Ed. 64, e202423403 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.He H. et al. Enantioselective Trifluoromethylazidation of Styrenyl Olefins Catalyzed by an Engineered Nonheme Iron Enzyme. Angew. Chem. Int. Ed. 64, e202423507 (2025). [DOI] [PubMed] [Google Scholar]
  • 23.Liu F. et al. Directed Evolution of Nonheme Iron Enzymes for Enantioselective Aminative Difunctionalization of Alkenes. JACS Au 5, 4472–4480 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Zhao L.-P. et al. Nonheme Fe 1,3-nitrogen migratases for asymmetric noncanonical amino acid synthesis. Nat. Chem. Biol. 21, 1773–1782 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Lin K. et al. Nonheme Fe Enzyme-Catalyzed Enantiodivergent Nitrogen Migration: Directed Evolution and Computational Study of Isopenicillin N Synthases for Biocatalytic Synthesis of Arylglycines. Angew. Chem. Int. Ed. 65, e24718 (2026). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Yuan T. et al. Biocatalytic Synthesis of N-Protected α-Amino Acids through 1,3-Nitrogen Migration by Nonheme Iron Enzymes. J. Am. Chem. Soc. 147, 44041–44047 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Cheng M. et al. Directed Evolution of a Nonheme Iron Enzyme to Access Chiral α-Amino Acid Derivatives by 1,3-Migratory Nitrene C(sp3)–H Insertion. Angew. Chem. Int. Ed. 65, e15741 (2026). [DOI] [PubMed] [Google Scholar]
  • 28.Solomon E. I. et al. Copper active sites in biology. Chem. Rev. 114, 3659–3853 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Jing Q. & Kazlauskas R. J. Regioselective Hydroformylation of Styrene Using Rhodium-Substituted Carbonic Anhydrase. ChemCatChem 2, 953–957 (2010). [Google Scholar]
  • 30.Key H. M., Clark D. S. & Hartwig J. F. Generation, Characterization, and Tunable Reactivity of Organometallic Fragments Bound to a Protein Ligand. J. Am. Chem. Soc. 137, 8261–8268 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Ghattas W. et al. CuII-Containing 1-Aminocyclopropane Carboxylic Acid Oxidase Is an Efficient Stereospecific Diels–Alderase. Angew. Chem. Int. Ed. 58, 14605–14609 (2019). [DOI] [PubMed] [Google Scholar]
  • 32.Shen X. et al. Enantioconvergent benzylic C(sp3)‒N coupling with a copper-substituted nonheme enzyme. Science 389, 741–746 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Zhang J. G. & Huang X. Directed Evolution of Copper-Substituted Nonheme Enzymes for Enantioselective Alkene Oxytrifluoromethylation. J. Am. Chem. Soc. 147, 29624–29630 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Mu X. et al. Unlocking Lewis acid catalysis in non-haem enzymes for an abiotic ene reaction. Nat. Catal. 8, 635–644 (2025). [Google Scholar]
  • 35.Agarwal V. et al. Enzymatic Halogenation and Dehalogenation Reactions: Pervasive and Mechanistically Diverse. Chem. Rev. 117, 5619–5674 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Vaillancourt F. H., Yeh E., Vosburg D. A., Garneau-Tsodikova S. & Walsh C. T. Nature's Inventory of Halogenation Catalysts: Oxidative Strategies Predominate. Chem. Rev. 106, 3364–3378 (2006). [DOI] [PubMed] [Google Scholar]
  • 37.Chiang C.-Y. et al. Copper-dependent halogenase catalyses unactivated C−H bond functionalization. Nature 638, 126–132 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Mondal S., Myers P. & Zhang S. Unsymmetric bimetallic centres in metalloproteins and synthetic models. Nat. Rev. Chem. 10, 101–116 (2026). [DOI] [PubMed] [Google Scholar]
  • 39.Jasniewski A. J. & Que L. Jr. Dioxygen Activation by Nonheme Diiron Enzymes: Diverse Dioxygen Adducts, High-Valent Intermediates, and Related Model Complexes. Chem. Rev. 118, 2554–2592 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Rolff M., Schottenheim J., Decker H. & Tuczek F. Copper-O2 reactivity of tyrosinase models towards external monophenolic substrates: molecular mechanism and comparison with the enzyme. Chem. Soc. Rev. 40, 4077–4098 (2011). [DOI] [PubMed] [Google Scholar]
  • 41.Pate J. E. et al. Spectroscopic studies of the charge transfer and vibrational features of binuclear copper(II) azide complexes: comparison to the coupled binuclear copper active site in met azide hemocyanin and tyrosinase. J. Am. Chem. Soc. 111, 5198–5209 (1989). [Google Scholar]
  • 42.Tepper A. W. J. W., Bubacco L. & Canters G. W. Structural Basis and Mechanism of the Inhibition of the Type-3 Copper Protein Tyrosinase from Streptomyces antibioticusby Halide Ions. J. Biol. Chem. 277, 30436–30444 (2002). [DOI] [PubMed] [Google Scholar]
  • 43.Tepper A. W. J. W., Bubacco L. & Canters G. W. Stopped-flow Fluorescence Studies of Inhibitor Binding to Tyrosinase from Streptomyces antibioticus. J. Biol. Chem. 279, 13425–13434 (2004). [DOI] [PubMed] [Google Scholar]
  • 44.Zhong F., Li R., Mai B. K., Liu P. & Fu G. C. Photoinduced copper-catalysed deracemization of alkyl halides. Nature 640, 107–113 (2025). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Wang Z.-Y. & Fu G. C. Copper-Catalyzed Enantioconvergent Nucleophilic Fluorination of Alkyl Electrophiles to Generate α-Fluoroamides. J. Am. Chem. Soc. 148, 14617–14623 (2026). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Chen C., Peters J. C. & Fu G. C. Photoinduced copper-catalysed asymmetric amidation via ligand cooperativity. Nature 596, 250–256 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Zhang Y.-F. et al. Asymmetric amination of alkyl radicals with two minimally different alkyl substituents. Science 388, 283–291 (2025). [DOI] [PubMed] [Google Scholar]
  • 48.Himmelwright R. S., Eickman N. C. & Solomon E. I. Chemical and spectroscopic conformation of an exogenous ligand bridge in half met hemocyanin. Biochem. Biophys. Res. Commun. 84, 300–305 (1978). [DOI] [PubMed] [Google Scholar]
  • 49.Westmoreland T. D., Wilcox D. E., Baldwin M. J., Mims W. B. & Solomon E. I. Detailed spectroscopic analysis of half-met hemocyanins: mixed-valent contributions to electronic properties and structure. J. Am. Chem. Soc. 111, 6106–6123 (1989). [Google Scholar]
  • 50.Tsai L.-C., Sjolin T., Langer V., Pascher T. & Nar H. Structure of the azurin mutant Phe114Ala from Pseudomonas aeruginosa at 2.6 Å resolution. Acta Cryst. D 51, 168–176 (1995). [DOI] [PubMed] [Google Scholar]
  • 51.Cunane L. M., Chen Z.-W., Durley R. C. E. & Mathews F. S. X-ray Structure of the Cupredoxin Amicyanin, from Paracoccus denitrificans, Refined at 1.31 Å Resolution. Acta Cryst. D 52, 676–686 (1996). [DOI] [PubMed] [Google Scholar]
  • 52.Sieracki N. A. et al. Copper–sulfenate complex from oxidation of a cavity mutant of Pseudomonas aeruginosa azurin. Proc. Natl. Acad. Sci. U.S.A. 111, 924–929 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Wilmot C. M., Hajdu J., McPherson M. J., Knowles P. F. & Phillips S. E. V. Visualization of Dioxygen Bound to Copper During Enzyme Catalysis. Science 286, 1724–1728 (1999). [DOI] [PubMed] [Google Scholar]
  • 54.Kruer-Zerhusen N. et al. Structure of a Thermobifida fusca lytic polysaccharide monooxygenase and mutagenesis of key residues. Biotechnol. Biofuels 10, 243 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Huffman M. A. et al. Design of an in vitro biocatalytic cascade for the manufacture of islatravir. Science 366, 1255–1259 (2019). [DOI] [PubMed] [Google Scholar]
  • 56.Ferro S. et al. Targeting Tyrosinase: Development and Structural Insights of Novel Inhibitors Bearing Arylpiperidine and Arylpiperazine Fragments. J. Med. Chem. 61, 3908–3917 (2018). [DOI] [PubMed] [Google Scholar]
  • 57.Do H., Kang E., Yang B., Cha H. J. & Choi Y. S. A tyrosinase, mTyr-CNK, that is functionally available as a monophenol monooxygenase. Sci. Rep. 7, 17267 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Son H. F. et al. Structural Basis for Highly Efficient Production of Catechol Derivatives at Acidic pH by Tyrosinase from Burkholderia thailandensis. ACS Catal. 8, 10375–10382 (2018). [Google Scholar]
  • 59.de Almeida Santos G., Englund A. N. B., Dalleywater E. L. & Røhr Å. K. Characterization of two bacterial tyrosinases from the halophilic bacterium Hahella sp. CCB MM4 relevant for phenolic compounds oxidation in wetlands. FEBS Open Bio 14, 2038–2058 (2024). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Kanteev M., Goldfeder M., Chojnacki M., Adir N. & Fishman A. The mechanism of copper uptake by tyrosinase from Bacillus megaterium. J. Biol. Inorg. Chem. 18, 895–903 (2013). [DOI] [PubMed] [Google Scholar]
  • 61.Abderrazak Y. & Reiser O. Copper Photocatalyzed Divergent Access to Organic Thio- and Isothiocyanates. ACS Catal. 14, 4847–4855 (2024). [Google Scholar]
  • 62.Kanteev M., Goldfeder M. & Fishman A. Structure–function correlations in tyrosinases. Protein Sci. 24, 1360–1369 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Sendovski M., Kanteev M., Ben-Yosef V. S., Adir N. & Fishman A. First Structures of an Active Bacterial Tyrosinase Reveal Copper Plasticity. J. Mol. Biol. 405, 227–237 (2011). [DOI] [PubMed] [Google Scholar]
  • 64.Himmelwright R. S., Eickman N. C., LuBien C. D., Solomon E. I. & Lerch K. Chemical and spectroscopic studies of the binuclear copper active site of Neurospora tyrosinase: comparison to hemocyanins. J. Am. Chem. Soc. 102, 7339–7344 (1980). [Google Scholar]
  • 65.Karlin K. D., Cohen B. I., Hayes J. C., Farooq A. & Zubieta J. Models for methemocyanin derivatives: structural and spectroscopic comparisons of related azido-coordinated (N3-) mono- and dinuclear copper(II) complexes. Inorg. Chem. 26, 147–153 (1987). [Google Scholar]
  • 66.Casella L., Carugo O., Gullotti M., Garofani S. & Zanello P. Hemocyanin and tyrosinase models. Synthesis, azide binding, and electrochemistry of dinuclear copper(II) complexes with poly(benzimidazole) ligands modeling the met forms of the proteins. Inorg. Chem. 32, 2056–2067 (1993). [Google Scholar]
  • 67.Healey D. F. & Strothkamp K. G. Inhibition of the catecholase and cresolase activity of mushroom tyrosinase by azide. Arch. Biochem. Biophys. 211, 86–91 (1981). [DOI] [PubMed] [Google Scholar]
  • 68.Dooley D. M. & McGuirl M. A. Thermodynamics of azide and thiocyanate binding to bovine copper-zinc superoxide dismutase. Inorg. Chem. 25, 1261–1264 (1986). [Google Scholar]
  • 69.Poore A. T. et al. Revisit the E2 Domain of Amyloid Precursor Protein: Ferroxidase, Superoxide and Peroxynitrite Scavenging Activities. Inorg. Chem. 62, 10780–10791 (2023). [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All data are available in the main text and the Supplementary Information. Plasmids encoding engineered tyrosinase variants reported in this study are available for research purposes from Y.Y. under a material transfer agreement with the University of California Santa Barbara.


Articles from bioRxiv are provided here courtesy of Cold Spring Harbor Laboratory Preprints

RESOURCES